How well does liver span as part of the consensus criteria for liver involvement in AL amyloidosis perform?

Anne F. Brungera Departments of Rheumatology & Clinical Immunology, University Medical Center Groningen, Groningen, the Netherlands;b Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, the NetherlandsCorrespondence[email protected]
View further author information

Ronald van Rheenenb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, the Netherlands;c Nuclear Medicine and Molecular Imaging, University Medical Center Groningen, Groningen, the Netherlands;d Department of Nuclear Medicine, Medical Center Leeuwarden, Leeuwarden, the NetherlandsView further author information

Reinold O. B. Gansb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, the Netherlands;e Internal Medicine, University Medical Center Groningen, Groningen, the NetherlandsView further author information

Bouke P. C. Hazenberga Departments of Rheumatology & Clinical Immunology, University Medical Center Groningen, Groningen, the Netherlands;b Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, the NetherlandsView further author information

Hans L. A. Nienhuisb Amyloidosis Center of Expertise, University Medical Center Groningen, Groningen, the Netherlands;e Internal Medicine, University Medical Center Groningen, Groningen, the NetherlandsView further author information

References

Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th international symposium on amyloid and amyloidosis. Am J Hematol. 2005;79(4):319–328. doi: 10.1002/ajh.20381
PubMed Web of Science ®Google Scholar
Gertz MA, Kyle RA. Hepatic amyloidosis (primary [AL], immunoglobulin light chain): The natural history in 80 patients. Am J Med. 1988;85(1):73–80. doi: 10.1016/0002-9343(88)90505-0
PubMed Web of Science ®Google Scholar
Hazenberg BPC, Van Rijswijk MH, Piers DA, et al. Diagnostic performance of 123I-labeled serum amyloid P component scintigraphy in patients with amyloidosis. Am J Med. 2006;119(4):e15–e24. doi: 10.1016/j.amjmed.2005.08.043
Web of Science ®Google Scholar
Kratzer W, Fritz V, Mason RA, et al. Factors affecting liver size. J Ultrasound Med. 2003;22(11):1155–1161. doi: 10.7863/jum.2003.22.11.1155
PubMed Web of Science ®Google Scholar

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

How well does liver span as part of the consensus criteria for liver involvement in AL amyloidosis perform?

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

How well does liver span as part of the consensus criteria for liver involvement in AL amyloidosis perform?

References

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date